First Time Loading...

Tianjin Chase Sun Pharmaceutical Co Ltd
SZSE:300026

Watchlist Manager
Tianjin Chase Sun Pharmaceutical Co Ltd Logo
Tianjin Chase Sun Pharmaceutical Co Ltd
SZSE:300026
Watchlist
Price: 3.86 CNY 1.58% Market Closed
Updated: May 4, 2024

Tianjin Chase Sun Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tianjin Chase Sun Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Tianjin Chase Sun Pharmaceutical Co Ltd
SZSE:300026
Revenue
¥6.1B
CAGR 3-Years
-2%
CAGR 5-Years
8%
CAGR 10-Years
11%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥9.7B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥22.3B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
¥39.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Revenue
¥2.5B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is Tianjin Chase Sun Pharmaceutical Co Ltd's Revenue?
Revenue
6.1B CNY

Based on the financial report for Dec 31, 2023, Tianjin Chase Sun Pharmaceutical Co Ltd's Revenue amounts to 6.1B CNY.

What is Tianjin Chase Sun Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
11%

Over the last year, the Revenue growth was -8%. The average annual Revenue growth rates for Tianjin Chase Sun Pharmaceutical Co Ltd have been -2% over the past three years , 8% over the past five years , and 11% over the past ten years .